Clearmind Medicine Valuation
| CMND Stock | USD 1.00 0.01 0.99% |
Today, the firm appears to be overvalued. Clearmind Medicine Common shows a prevailing Real Value of $0.83 per share. The current price of the firm is $1.0. Our model approximates the value of Clearmind Medicine Common from analyzing the firm fundamentals such as current valuation of 765.26 K, and Return On Equity of -1.39 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Clearmind Medicine's valuation include:
Overvalued
Today
Please note that Clearmind Medicine's price fluctuation is extremely dangerous at this time. Calculation of the real value of Clearmind Medicine Common is based on 3 months time horizon. Increasing Clearmind Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Clearmind stock is determined by what a typical buyer is willing to pay for full or partial control of Clearmind Medicine Common. Since Clearmind Medicine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clearmind Stock. However, Clearmind Medicine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0 | Real 0.83 | Hype 1.0 | Naive 0.96 |
The real value of Clearmind Stock, also known as its intrinsic value, is the underlying worth of Clearmind Medicine Common Company, which is reflected in its stock price. It is based on Clearmind Medicine's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Clearmind Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Clearmind Medicine Common helps investors to forecast how Clearmind stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clearmind Medicine more accurately as focusing exclusively on Clearmind Medicine's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Clearmind Medicine's intrinsic value based on its ongoing forecasts of Clearmind Medicine's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Clearmind Medicine's closest peers. If more than one evaluation category is relevant for Clearmind Medicine we suggest using both methods to arrive at a better estimate.
Clearmind Medicine Cash |
|
Clearmind Valuation Trend
Comparing Clearmind Medicine's enterprise value against its market capitalization is a good way to estimate the value of Clearmind Medicine Common uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Clearmind Medicine Total Value Analysis
Clearmind Medicine Common is currently estimated to have valuation of 765.26 K with market capitalization of 5.38 M, debt of 53.14 K, and cash on hands of 1.65 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Clearmind Medicine fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
765.26 K | 5.38 M | 53.14 K | 1.65 K |
Clearmind Medicine Asset Utilization
One of the ways to look at asset utilization of Clearmind is to check how much profit was generated for every dollar of assets it reports. Clearmind Medicine Common shows a negative utilization of assets of -0.52 percent, losing $0.005223 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Clearmind Medicine Common shows how unproductive it operates for each dollar spent on its assets.Clearmind Medicine Ownership Allocation
Almost 86.03 percent of Clearmind Medicine outstanding shares are held by general public with 2.79 (percent) owned by insiders and only 11.18 % by other corporate entities.Clearmind Medicine Profitability Analysis
Net Loss for the year was (5.25 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Clearmind Medicine's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Clearmind Medicine and how it compares across the competition.
About Clearmind Medicine Valuation
The stock valuation mechanism determines Clearmind Medicine's current worth on a weekly basis. Our valuation model uses a comparative analysis of Clearmind Medicine. We calculate exposure to Clearmind Medicine's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Clearmind Medicine's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -24 K | -25.2 K |
Clearmind Medicine Growth Indicators
Investing in growth stocks can be very risky. If the company such as Clearmind Medicine does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.3 M |
Clearmind Medicine Current Valuation Indicators
Valuation refers to the process of determining the present value of Clearmind Medicine Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Clearmind we look at many different elements of the entity such as Clearmind's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Clearmind Medicine, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Clearmind Medicine's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Clearmind Medicine's worth.Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |